Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new release of the page content. No visible content or functionality changes are indicated by this update.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedLocation entries for Chile are updated to use shorter regional labels (e.g., “Araucania” and “Valparaiso”) alongside the same city and site details. The page footer revision version is also incremented from v3.5.0 to v3.5.3.SummaryDifference0.4%

- Check66 days agoChange DetectedRevision label updated to v3.5.0. The previous label v3.4.3 was removed.SummaryDifference0.0%

- Check81 days agoChange Detected- Added Revision: v3.4.3 - Deleted Revision: v3.4.2SummaryDifference0.0%

- Check103 days agoChange DetectedThe page now displays 'Revision: v3.4.2' and no longer shows 'Revision: v3.4.1'.SummaryDifference0.0%

- Check110 days agoChange DetectedPlain Language Summary has been added to the Study Details page, and the record shows a new revision (v3.4.1). The previous revision (v3.4.0) was removed and new date entries for 2026-02-05, 2026-01-15, and 2025-12 were added.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.